Only FLASH achieves total aorto-ostial stent apposition

logo-360
  • Optimize Patient Outcomes
  • Total & Efficient Lesion Coverage
  • Streamlined Vessel Reaccess

The Challenge

Suboptimal Lesion Coverage

Standard PTCA catheters are unable to create a smooth transition at the ostium creating suboptimal lesion coverage, which is associated with poor outcomes.1

flash-vs-standard-of-care@2x

The solution

Flash3D_NoBackground_02_v2-fade

97%

of lesions demonstrated complete stent apposition2,3

Novel Dual-Balloon Technology

Available for both coronary and peripheral indications.

flash_01

EASY DELIVERY AND CATHETER POSITIONING

The FLASH system is designed to confidently access and address challenging aorto-ostial stenting, providing total lesion coverage.

flash_02

TRUE 360° FLARED APPOSITION

Novel 2-in-1 dual balloon design allows for inflation of a non-compliant distal balloon to anchor the system, while inflation of the compliant, low-pressure proximal balloon conforms the stent to the wall of the ostium.

flash_03

STREAMLINED
REACCESS

With TRUE 360° wall apposition achieved, a smooth transition is created for improved reaccess in future interventions.1,2

confident outcomes

restenosis

The FLASH System demonstrates consistently low restenosis at 6 months, below the 9% rate reported for accurate stent placement in ostial lesions.

Excellent Final Result

RCA Ostial Stenosis

Prior to stent deployment
Prior to stent deployment
Stent protruding into aorta
Stent protruding into aorta
Post-dilatation with FLASH
Post-dilatation with FLASH
TRUE 360° result
TRUE 360° result

FEVAR

Stent protruding into aorta
Stent protruding into aorta
Post-dilatation with FLASH
Post-dilatation with FLASH
TRUE 360° result
TRUE 360° result

Resources

Case studies, training videos, and more.

ordering information

Ostial-Flash-Ordering-Chart@2x

Email us your order at customerservice@ostialflash.com
Or call: 1.844.FLASH.11

newsroom

Ostial Reaches 15,000 FLASH™ Systems Sold

September 2, 2020

Ostial Corporation Reaches 15,000 FLASH™ System Units Sold May 12, 2020 CAMPBELL, Calif., — Ostial Corporation (Ostial), a private medical technology company focused on addressing the clinical challenges of aorto-ostial interventions, today reached a new milestone, passing the mark of 15,000 commercial units sold of its FLASH™ Aorto-Ostial Angioplasty System (FLASH System) in over 300 […]

Read More

Find out more about FLASH™

§compared to non-ostial lesions

  1. Cook, et al. Impact of incomplete stent apposition on long-term clinical outcome after drug-eluting stent implantation European Heart Journal 2012. 33:1334-1343.
  2. Data on file at Ostial Corporation.
  3. Sanghvi K, Morris T, Kovach R. Optimal Aorto-ostial Lesion Treatment With Flash Ostial Balloon Is Feasible and Safe. JACC. 2016;9(4). Supplement S.
  4. Nguyen-Trong P, Martinez Parachini J, Resendes E, et al. Procedural Outcomes With Use of the Flash Ostial System in Aorto-Coronary Ostial Lesions. Catheter Cardiovasc Interv.
    2016;88(7):1067-1074.
  5. Data on file at Ostial Corporation.
  6. Dishmon D, Elhaddi A, Packard K, et al. High Incidence of Inaccurate Stent Placement in the Treatment of Coronary Aorto-Ostial Disease. JIC. 2011;23(8).

Indications, Contraindications, Warnings & Precautions

The FLASH™ Ostial system in a specialty balloon device and should only be used by physicians who are trained to use it.
To request a complete copy of the IFU or user training, please contact customer service at customerservice@ostialflash.com.